(Q34390072)

1 August 2017

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. (English)

1 reference

Infectious Diseases Society of America

1 August 2017

12

object named as

Infectious Diseases Society of America

1 reference

1 August 2017

3

Per Ljungman

1 reference

1 August 2017

10

Harry Keyserling

1 reference

1 August 2017

2

Myron J Levin

1 reference

1 August 2017

Lorry G Rubin

1

1 reference

1 August 2017

E Graham Davies

4

1 reference

1 August 2017

Robin Avery

5

1 reference

1 August 2017

Marcie Tomblyn

6

1 reference

1 August 2017

Athos Bousvaros

7

1 reference

1 August 2017

Shireesha Dhanireddy

8

1 reference

1 August 2017

Lillian Sung

9

1 reference

1 August 2017

Insoo Kang

11

1 reference

1 August 2017

language of work or name

English

0 references

publication date

4 December 2013

1 reference

Clinical Infectious Diseases

1 August 2017

1 reference

1 August 2017

58

1 reference

1 August 2017

3

1 reference

1 August 2017

e44-100

1 reference

Immunization of pediatric solid organ transplant candidates and recipients

1 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Attenuated varicella virus vaccine in children with renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effectiveness of varicella vaccine in children infected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

How to make sense of pertussis immunogenicity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Opsonic requirements for intravascular clearance after splenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune responses to varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effect of immunization against rubella on lactation products. II. Maternal-neonatal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

The postmarketing safety profile of varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Secondary transmission of varicella vaccine virus in a chronic care facility for children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Rotavirus vaccines: viral shedding and risk of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Mandatory influenza vaccination of health care workers: translating policy to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Yellow fever vaccine: a successful vaccination of an immunocompromised patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow Fever vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Development of Resistance to Acyclovir during Chronic Infection with the Oka Vaccine Strain of Varicella‐Zoster Virus, in an Immunosuppressed Child

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

The varicella vaccine. Clinical trials in immunocompromised individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Varicella vaccination of immunocompromised children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

B cells and transplantation: an educational resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Herpes zoster in patients taking TNFalpha antagonists for chronic inflammatory joint disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune Response of a Patient with Deficiency of the Fourth Component of Complement and Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Chronic granulomatous disease. Report on a national registry of 368 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Chronic granulomatous disease: the European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Defective T-lymphocyte signal transduction and function in leukocyte adhesion deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Presumed BCG infection in a boy with chronic granulomatous disease. A report of a case and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Hazards of early BCG vaccination: BCGitis in a patient with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Disseminated Bacillus Calmette-Guérin lymphadenitis in a patient with gp91phox- chronic granulomatous disease 25 years after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Vaccine-induced polioencephalomyelitis in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Polio vaccine virus-associated meningoencephalitis in an infant with transient hypogammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Vaccine-derived poliovirus from long term excretors and the end game of polio eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Search for poliovirus long-term excretors among patients affected by agammaglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Disseminated measles infection after vaccination in a child with a congenital immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Severe combined immunodeficiency: a cohort of 40 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Do children infected with HIV receiving HAART need to be revaccinated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pertussis immunization in HIV-1-infected infants: a model to assess the effects of repeated T cell-dependent antigen administrations on HIV-1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Impaired response to hepatitis B vaccine in HIV infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

XVII International AIDS Conference: From Evidence to Action - Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Low Prevalence of Ongoing Hepatitis B Viremia in HIV-Positive Individuals with Isolated Antibody to Hepatitis B Core Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeficiency Virus–Infected Patients: A Double‐Blind, Randomized, Placebo‐Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody responses to hepatitis A virus vaccination in thai hiv-infected children with immune recovery after antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Hepatitis B vaccination in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune response to conjugated meningococcal C vaccine in pediatric oncology patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune recovery in children with malignancy after cessation of chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Efficacy of the influenza vaccine in patients with malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Epidemiology of influenza A virus infection in patients with acute or chronic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Seroconversion after influenza vaccination in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Response to influenza virus vaccination during chemotherapy in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Cost-effectiveness of influenza vaccination in working-age cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Fulminant hepatic failure with hepatitis B virus reactivation after rituximab treatment in a patient with resolved hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Designed transfer of specific immune responses with bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Transfer and Persistence of Viral Antibody-Producing Cells in Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunological reconstitution following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Administration of live attenuated varicella vaccine to children with cancer before starting chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pneumococcal Infections After Human Bone-Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Severe measles in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Early measles vaccination in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Response to HBV vaccination in patients with severe liver disease. Absence of an HLA effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza vaccination in the organ transplant recipient: review and summary recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunization of pediatric solid-organ transplantation candidates: immunizations in transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunization in children with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Variability in immunization guidelines in children before and after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza infection in patients before and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pneumococcal polysaccharide vaccine in children with chronic renal disease: a prospective study of antibody response and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity of hepatitis A vaccine in decompensated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Varicella vaccination in pediatric kidney transplant candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza vaccination in heart transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza vaccine antibody responses in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza vaccination in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

The humoral immune response to influenza vaccination in lung transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Cell-mediated immune response to influenza vaccination in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Outcomes associated with influenza vaccination in the first year after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pneumococcal vaccine response in cirrhosis and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Human papillomavirus infection in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Live virus immunization after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Varicella infection following varicella vaccination in a liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effects of influenza immunization on humoral and cellular alloreactivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune response to influenza vaccine in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Cochlear implants in children: surgical site infections and prevention and treatment of acute otitis media and meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunogenicity of pneumococcal vaccination of patients with cochlear implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: Report of two successful cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Hepatitis A and B Vaccination Practices for Ambulatory Patients Infected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Varicella vaccination in children with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients After Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Bordetella pertussis respiratory infection following hematopoietic stem cell transplantation: time for universal vaccination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Recommendation for Mandatory Influenza Immunization of All Health Care Personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Varicella vaccination in a child with acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

Immune Responses of Splenectomized Trauma Patients to the 23-Valent Pneumococcal Polysaccharide Vaccine at 1 versus 7 versus 14 Days after Splenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT684

21 January 2018

Identifiers

DOI

10.1093/CID/CIT684

1 reference

1 August 2017

1 reference